QuantiPath
PrivateLast Round
Seed Round
Apr 28, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QuantiPath is a biotechnology company that operates a genetic testing technology platform intended for precise identification and quantification of Salmonella serovars.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Compliance, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QuantiPath Comparables
Compare QuantiPath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neogen Corporation | 73% | |
| Bio-Rad Laboratories | 73% | |
| Thermo Fisher Scientific Inc. | 73% | |
QuantiPath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 28, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Apr 28, 2026
Raised $1M in Seed Round funding.
QuantiPath Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about QuantiPath's valuation, stock price, and market status.